Trial Profile
A Retrospective study of Clofarabine/cyclophosphamide in patients with refractory leukaemia before stem cell transplantation.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Sep 2015
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary) ; Cyclophosphamide
- Indications Acute myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Therapeutic Use
- 29 Sep 2015 New trial record